locally-advanced BCC after resistance to 26 wks of nivolimab alone (IMAGE)

Johns Hopkins Medicine

locally-advanced BCC after resistance to 26 wks of nivolimab alone

Caption

Durable, ongoing near-complete response to nivolimab + relatlimab in a 64 year old with locally-advanced BCC after resistance to 26 wks of nivolimab alone.

Credit

Evan Lipson, M.D.

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.